What is he best known for?
The fields of study he is best known for:
Mark S. Smeltzer mostly deals with Microbiology, Staphylococcus aureus, Biofilm, Mutant and Virulence.
He works in the field of Microbiology, focusing on Micrococcaceae in particular.
His Micrococcaceae research includes themes of Staphylococcal infections, Staphylococcus and Polymerase chain reaction.
His work deals with themes such as Antibiotics, Pathogenesis, Pathology, Cytoskeleton and Actin, which intersect with Staphylococcus aureus.
His research integrates issues of Arginine transport, Arginine, Arginine deiminase and Intrinsic resistance in his study of Biofilm.
His study in Mutant is interdisciplinary in nature, drawing from both Mutation, Lysis and Gene expression.
His most cited work include:
- The cidA murein hydrolase regulator contributes to DNA release and biofilm development in Staphylococcus aureus. (486 citations)
- Global Gene Expression in Staphylococcus aureus Biofilms (474 citations)
- Photothermal Nanotherapeutics and Nanodiagnostics for Selective Killing of Bacteria Targeted with Gold Nanoparticles (453 citations)
What are the main themes of his work throughout his whole career to date?
Mark S. Smeltzer mainly investigates Microbiology, Staphylococcus aureus, Biofilm, Mutant and Virulence.
His Microbiology research is multidisciplinary, relying on both Proteases, Vancomycin, Protease and Mutation.
His studies deal with areas such as Extracellular, In vivo, Osteomyelitis and Pathogenesis as well as Staphylococcus aureus.
His biological study spans a wide range of topics, including In vitro and Staphylococcus epidermidis.
His Mutant research incorporates elements of Phenotype, Plasmid and Regulation of gene expression.
His Virulence research integrates issues from Pathogen and Operon.
He most often published in these fields:
- Microbiology (59.85%)
- Staphylococcus aureus (57.66%)
- Biofilm (36.50%)
What were the highlights of his more recent work (between 2016-2021)?
- Staphylococcus aureus (57.66%)
- Microbiology (59.85%)
- Biofilm (36.50%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Staphylococcus aureus, Microbiology, Biofilm, Antibiotics and Vancomycin.
His work carried out in the field of Staphylococcus aureus brings together such families of science as Proteases, Protease, Osteomyelitis, In vivo and Virulence.
He interconnects Extracellular and Mutant in the investigation of issues within Proteases.
His Mutant study combines topics from a wide range of disciplines, such as Mutation and Phenotype.
Mark S. Smeltzer studies Microbiology, namely Amikacin.
Many of his research projects under Biofilm are closely connected to Clinical Practice, Cost of care, Joint infections and Musculoskeletal infection with Clinical Practice, Cost of care, Joint infections and Musculoskeletal infection, tying the diverse disciplines of science together.
Between 2016 and 2021, his most popular works were:
- 2018 international consensus meeting on musculoskeletal infection: Summary from the biofilm workgroup and consensus on biofilm related musculoskeletal infections. (44 citations)
- General Assembly, Prevention, Antiseptic Irrigation Solution: Proceedings of International Consensus on Orthopedic Infections (17 citations)
- Versatility of targeted antibiotic-loaded gold nanoconstructs for the treatment of biofilm-associated bacterial infections. (17 citations)
In his most recent research, the most cited papers focused on:
His primary scientific interests are in Antibiotics, Biofilm, Staphylococcus aureus, Microbiology and Pseudomonas aeruginosa.
Mark S. Smeltzer has included themes like Benzoic acid, Vancomycin and Bacillus subtilis in his Antibiotics study.
His Biofilm study incorporates themes from Extracellular, Protease, Mutation and Proteases.
He combines subjects such as Hemolysis, Rifampicin, Antimicrobial, Mutant and Virulence with his study of Staphylococcus aureus.
His Microbiology study frequently draws parallels with other fields, such as Acinetobacter baumannii.
His work is dedicated to discovering how Pseudomonas aeruginosa, In vivo are connected with Ciprofloxacin, Escherichia coli, Osteomyelitis, Surgical Sponges and Amikacin and other disciplines.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
